wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38909657-2D62D11A-A960-417F-A5E9-D89E6EFD5CDC
Q38909657-2D62D11A-A960-417F-A5E9-D89E6EFD5CDC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38909657-2D62D11A-A960-417F-A5E9-D89E6EFD5CDC
The high price of anticancer drugs: origins, implications, barriers, solutions.
P2860
Q38909657-2D62D11A-A960-417F-A5E9-D89E6EFD5CDC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38909657-2D62D11A-A960-417F-A5E9-D89E6EFD5CDC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
063a308f5ae21602883d477ffde27d8a59d31830
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).